http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019228502-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382bae8d5e61a815f55e2e2a0b642f3a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecbb95a4b4754d20402bedcef32cb17
publicationDate 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019228502-A1
titleOfInvention Lentiviral vector used for treatment of sanfilippo a syndrome, lentivirus, and preparation method and application thereof
abstract The present application provides a lentiviral vector used for the treatment of sanfilippo A syndrome, lentivirus, and preparation method and application thereof, wherein the lentiviral vector may be obtained by applying pTYF or modifying a pTYF lentiviral vector at the 5'-end splice donor site and further comprises a SGSH gene. The SGSH gene is specifically connected into the pTYF or the modified lentiviral vector of the present invention, thereby achieving a more efficient gene delivery while ensuring safety, significantly increasing the expression level of the SGSH gene in transgenic brain-related cells, and more efficiently accomplishing the transfer of normal genes during the gene therapy of sanfilippo A syndrome.
priorityDate 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6207455-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0040741-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423387664
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477714
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BFX4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42266
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1RZ89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PTW7

Total number of triples: 42.